徐强 教授 博士生导师





办公电话：
邮政编码： 210023

联系地址：
电子邮件： qiangxu@nju.edu.cn








个人简介
研究方向
科研成果





个人简介


学术兼职



研究方向

徐强，南京大学生命科学学院教授，博导，副院长，医药生物技术国家重点实验室PI，课题组长。教育部********，国家****科学基金获得者。主要从事免疫药理学、分子药理学等领域的研究。以药理学为桥梁，研究触角向基础医学、临床医学和化学生物学自然交叉延伸，实现从新的角度阐释疾病的发生发展机理、寻找新的药物作用靶点或生物分子事件、进而研制新型药物的目标。主要研究方向包括：免疫应答与炎症的分子基础及其选择性调控；炎-癌转化的分子机制研究；基于小分子化合物作用特点的化学生物学研究等。
主持多项国家级研究课题包括国家自然科学基金重点项目、国家科技重大专项等研究课题的资助。发表原著论文220余篇，其中SCI收载170余篇，总影响因子近600，包括Autophagy, Am. J. Pathol., Angew. Chem. Int. Ed., Biochem.Pharmacol., J. Allergy Clin. Immunol., J Immunol., Leukemia, Mol. Pharmacol. Nat.Comm.,等杂志。
担任国际刊物Journal of Pharmacological Sciences杂志副主编以及Biochemical Pharmacology、Journal of Traditional Medicines、Asian Journal of Traditional Medicines、《中国药理学通报》、《中国免疫学杂志》、《中国天然药物》等杂志的编委。国家药品审评专家，国家中药品种保护审评委员会委员，中国药理学会抗炎免疫药理专业委员会副主任委员，中国药理学会中药药理专业委员会常委，江苏省药理学会副理事长。获第四届中国青年科技奖（1994年），首届吴阶平-保罗杨森医药学研究奖二等奖（1994年），入选教育部跨世纪优秀人才培养计划（1995年）；国家中青年有突出贡献专家称号（1996年）；首届江苏青年科学家奖提名奖（1996年）；国家****科学基金获得者（1999年），教育部“****”****（2001年）。作为第一完成人获2011年度教育部自然科学一等奖。

代表性论著（*通讯作者）
1. Wenjie Guo,Yang Sun,Wen Liu,Xingxin Wu,Lele Guo,Peifen Cai, Xuefeng Wu,Xudong Wu,Yan Shen,Yongqian Shu,Yanhong Gu,Qiang Xu*.Small molecule-driven mitophagy-mediated NLRP3 inflammasome inhibition is responsible for the prevention of colitis-associated cancer.Autophagy 2014; 10(6):972–985. 2.Li Zhang, Yang Sun, Mingjian Fei, Cheng Tan, Jing Wu, Jie Zheng, Jiqing Tang, Wei Sun, Zhaoliang Lv, Jiandong Bao, Qiang Xu* and Huixin Yu. Disruption of chaperone-mediated autophagy dependent degradation of MEF2A by oxidative stress-induced lysosome destabilization. Autophagy2014; 10(6):1015-35.
3.Li W, Ouyang Z, Zhang Q, Wang L, Shen Y, Wu X, Gu Y, Shu Y, Yu B, Wu X, Sun Y, Xu Q*. SBF-1 exerts strong anticervical cancer effect through inducing endoplasmic reticulum stress-associated cell death via targeting sarco/endoplasmic reticulum Ca(2+)-ATPase 2. Cell Death Dis2014; 5: e1581.
4.Wang X, Zhang A, Gao J, Chen W, Wang S, Wu X, Shen Y, Ke Y, Hua Z, Tan R, Sun Y, Xu Q*. Trichomide A, a natural cyclodepsipeptide, exerts immunosuppressive activity against activated T lymphocytes by upregulating SHP2 activation to overcome contact dermatitis. J Invest Dermatol2014; 134(11): 2737-46.
5??.????????Luo Q, Sun Y, Gong FY, Liu W, Zheng W, Shen Y, Hua ZC, Feng GS, Xu Q*. ??Blocking initial infiltration of pioneer CD8+ T cells into the CNS via inhibition of SHP-2 ameliorates experimental autoimmune encephalomyelitis in mice. ????????Br J Pharmacol2014; 171: 1706-21.
6. WJ Guo, YM Zhang, L Zhang, B Huang, FF Tao, W Chen, ZJ Guo*, Q Xu*, Y Sun*. Novel monofunctional platinum (II) complex Mono-Pt induces apoptosis-independent autophagic cell death in human ovarian carcinoma cells distinct from cisplatin. Autophagy2013; 9: 996-1008.

7. Q Luo, Y Sun*, W Liu, C Qian, B Jin, F Tao, Y Gu, X Wu, Y Shen, Q Xu*. A novel disease-modifying antirheumatic drug, iguratimod, ameliorates murine arthritis by blocking IL-17 signaling, distinct from methotrexate and leflunomide.J Immunol2013; 191: 4969-4978.
8.. T Zhang, W Guo, Y Yang, W Liu, L Guo, Y Gu, Y Shu, L Wang, X Wu, Z Hua, Y Ke, Y Sun, Y Shen, Q Xu*. Loss of SHP-2 activity in CD4⁺T cells promotes melanoma progression and metastasis. Sci Rep2013; 3: 2845.
9. X Wu, W Guo, L Wu, Y Gu, L Gu, S Xu, X Wu, Y Shen, Y Ke, R Tan, Y Sun, Q Xu*. Selective sequestration of STAT1 in the cytoplasm via phosphorylated SHP-2 ameliorates murine experimental colitis. J Immunol2012, 189: 3497-3507.
10. L Wang, L Wang, Y Gu, Y Shu, Y Shen,Q Xu*. Integrin a6high cell population functions as an initiator in tumorigenesis and relapse of human liposarcoma. Mol Cancer Ther2011; 10: 2276-2286.
11. L Wang, L Wang, R Song, Y Shen, Y Sun, Y Gu, Y Shu, Q Xu*. Targeting sarcoplasmic/endoplasmic reticulum Ca2+-ATPase 2 by curcumin induces ER stress-associated apoptosis for treating human liposarcoma. Mol Cancer Ther2011; 10: 461-471.
12. W Zhao, Y Gu, R Song, B Qu, Q Xu*. Sorafenib inhibits activation of human peripheral blood T cells by targeting LCK phosphorylation. Leukemia2008; 22(6): 1226-33.
13. J Guo,Q Xu*,T Chen. Identification of a new metabolite of astilbin, 3'-O-methylastilbin, and its immunosuppressive activity against contact dermatitis. Clin Chem2007; 53: 465-471.
14. M Fei, X Wu, Q Xu*. Astilbin inhibits contact hypersensitivity via negative cytokine regulation distinct from cyclosporin A. J Allergy Clin Immunol 2005; 116(6): 1350-1356.
15. X Wu,?H Zeng, X Zhang,?Y Zhao,?H Sha, X Ge, M Zhang, X Gao, Q Xu*. Phosphatase of Regenerating Liver-3 Promotes Motility and Metastasis of Mouse Melanoma Cells. Am J Pathol2004; 164(6): 2039-2054.
实验室网站：molpharm.nju.edu.cn



获奖情况


科研成果
代表性论著（*通讯作者）
1. Wenjie Guo,Yang Sun,Wen Liu,Xingxin Wu,Lele Guo,Peifen Cai, Xuefeng Wu,Xudong Wu,Yan Shen,Yongqian Shu,Yanhong Gu,Qiang Xu*. Small molecule-driven mitophagy-mediated NLRP3 inflammasome inhibition is responsible for the prevention of colitis-associated cancer. Autophagy 2014; 10(6):972–985.
2.Li Zhang, Yang Sun, Mingjian Fei, Cheng Tan, Jing Wu, Jie Zheng, Jiqing Tang, Wei Sun, Zhaoliang Lv, Jiandong Bao, Qiang Xu* and Huixin Yu. Disruption of chaperone-mediated autophagy dependent degradation of MEF2A by oxidative stress-induced lysosome destabilization. Autophagy 2014; 10(6):1015-35.
3.Li W, Ouyang Z, Zhang Q, Wang L, Shen Y, Wu X, Gu Y, Shu Y, Yu B, Wu X, Sun Y, Xu Q*. SBF-1 exerts strong anticervical cancer effect through inducing endoplasmic reticulum stress-associated cell death via targeting sarco/endoplasmic reticulum Ca(2+)-ATPase 2. Cell Death Dis 2014; 5: e1581.
4.Wang X, Zhang A, Gao J, Chen W, Wang S, Wu X, Shen Y, Ke Y, Hua Z, Tan R, Sun Y, Xu Q*. Trichomide A, a natural cyclodepsipeptide, exerts immunosuppressive activity against activated T lymphocytes by upregulating SHP2 activation to overcome contact dermatitis. J Invest Dermatol 2014; 134(11): 2737-46.
5??.????????Luo Q, Sun Y, Gong FY, Liu W, Zheng W, Shen Y, Hua ZC, Feng GS, Xu Q*. ??Blocking initial infiltration of pioneer CD8+ T cells into the CNS via inhibition of SHP-2 ameliorates experimental autoimmune encephalomyelitis in mice. ????????Br J Pharmacol 2014; 171: 1706-21.
6. WJ Guo, YM Zhang, L Zhang, B Huang, FF Tao, W Chen, ZJ Guo*, Q Xu*, Y Sun*. Novel monofunctional platinum (II) complex Mono-Pt induces apoptosis-independent autophagic cell death in human ovarian carcinoma cells distinct from cisplatin. Autophagy 2013; 9: 996-1008.
7. Q Luo, Y Sun*, W Liu, C Qian, B Jin, F Tao, Y Gu, X Wu, Y Shen, Q Xu*. A novel disease-modifying antirheumatic drug, iguratimod, ameliorates murine arthritis by blocking IL-17 signaling, distinct from methotrexate and leflunomide.J Immunol2013; 191: 4969-4978.
8. T Zhang, W Guo, Y Yang, W Liu, L Guo, Y Gu, Y Shu, L Wang, X Wu, Z Hua, Y Ke, Y Sun, Y Shen, Q Xu*. Loss of SHP-2 activity in CD4+ T cells promotes melanoma progression and metastasis. Sci Rep 2013; 3: 2845.
9. X Wu, W Guo, L Wu, Y Gu, L Gu, S Xu, X Wu, Y Shen, Y Ke, R Tan, Y Sun, Q Xu*. Selective sequestration of STAT1 in the cytoplasm via phosphorylated SHP-2 ameliorates murine experimental colitis. J Immunol 2012, 189: 3497-3507.
10. L Wang, L Wang, Y Gu, Y Shu, Y Shen,Q Xu*. Integrin a6high cell population functions as an initiator in tumorigenesis and relapse of human liposarcoma. Mol Cancer Ther 2011; 10: 2276-2286.
11. L Wang, L Wang, R Song, Y Shen, Y Sun, Y Gu, Y Shu, Q Xu*. Targeting sarcoplasmic/endoplasmic reticulum Ca2+-ATPase 2 by curcumin induces ER stress-associated apoptosis for treating human liposarcoma. Mol Cancer Ther 2011; 10: 461-471.
12. W Zhao, Y Gu, R Song, B Qu, Q Xu*. Sorafenib inhibits activation of human peripheral blood T cells by targeting LCK phosphorylation. Leukemia 2008; 22(6): 1226-33.
13. J Guo, Q Xu*,T Chen. Identification of a new metabolite of astilbin, 3'-O-methylastilbin, and its immunosuppressive activity against contact dermatitis. Clin Chem 2007; 53: 465-471.
14. M Fei, X Wu, Q Xu*. Astilbin inhibits contact hypersensitivity via negative cytokine regulation distinct from cyclosporin A. J Allergy Clin Immunol 2005; 116(6): 1350-1356.
15. X Wu,?H Zeng, X Zhang,?Y Zhao,?H Sha, X Ge, M Zhang, X Gao, Q Xu*. Phosphatase of Regenerating Liver-3 Promotes Motility and Metastasis of Mouse Melanoma Cells. Am J Pathol 2004; 164(6): 2039-2054.